SELLAS Life Sciences (SLS) Enterprise Value Growth (5y) (2015 - 2026)
SELLAS Life Sciences (SLS) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -303.61% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -40.13% |
| Jun 30, 2025 | -49.92% |
| Mar 31, 2025 | 56.93% |
| Dec 31, 2024 | -168.23% |
| Sep 30, 2024 | -18.24% |
| Jun 30, 2024 | 6.52% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 2.59% |
| Sep 30, 2023 | 16.69% |
| Jun 30, 2023 | 59.01% |
| Mar 31, 2023 | -22.65% |
| Dec 31, 2022 | -6.08% |
| Sep 30, 2022 | 62.17% |
| Jun 30, 2022 | 62.56% |
| Mar 31, 2022 | 64.64% |
| Dec 31, 2021 | 55.98% |
| Sep 30, 2021 | -1.40% |
| Jun 30, 2021 | 65.20% |